We have developed the website to support you in the luteal phase of your fertility journey. We understand it is important for you to know why you have been prescribed this treatment and how it works.

Here you will find information on:

Please always take Utrogestan Vaginal exactly as your doctor has advised you to and read the package leaflet that comes with your medicine before using it.

Don’t forget there is a free app that you can download from the app store or google play.

The app has the added benefit of a dose reminder tool that will alert you when you need to take your next dose of Utrogestan Vaginal.

Free App to support your journey

Why have you been prescribed

UTROGESTAN VAGINAL

 

As part of your assisted fertility treatment, the medication you take to control ovulation and the embryo transfer procedure can disrupt your body’s natural progesterone production. This can result in low levels of progesterone.

In the luteal phase (the part of your menstrual cycle after ovulation) progesterone is needed to thicken the uterus wall (called the endometrium), ready for an egg to implant.

Utrogestan Vaginal contains progesterone and offers ‘luteal phase support’. When inserted into the vagina, progesterone helps increase the chances of successful implantation and pregnancy.

How to use

UTROGESTAN VAGINAL

 

Always follow the instructions given to you by your doctor.

Before you start:

  • Applicators are supplied to ease insertion of capsule into the vagina.
  • Read the package leaflet that comes with your medicine before using it.
  • Practice good hygiene and wash your hands before and after inserting Utrogestan Vaginal.
  • Use the Utrogestan Vaginal applicator that comes with your Utrogestan Vaginal capsules.

After you have inserted Utrogestan Vaginal

  • Dispose of the applicator – they are for single use only.
  • Wearing a panty liner is recommended, as there may be some leakage from the dissolved capsule.

When not to use

UTROGESTAN VAGINAL

 

Always follow the instructions given to you by your doctor and read the package leaflet that comes with your medicine for a full list of warnings and precautions.

Do not use Utrogestan Vaginal if:

  • You are allergic (hypersensitive) to progesterone, soya lecithin, peanut, soya, or to any of the other ingredients of this medicine
  • You have severe liver disease
  • You have unexplained vaginal bleeding
  • You have mammary or genital tract carcinoma
  • You have thrombophlebitis
  • You have or have had blood clots in a vein (thrombosis), such as in the legs (deep venous thrombosis) or the lungs (pulmonary embolism)
  • You have cerebral haemorrhage
  • You have a rare blood problem called “porphyria” which is passed down in families (inherited)
  • You have had a missed abortion

Precaution

Utrogestan Vaginal 200mg contains soya lecithin. As there is a possible relationship between allergy to soya and allergy to peanut, people with soya or peanut allergy should avoid using Utrogestan Vaginal 200mg. For the avoidance of doubt, Utrogestan Vaginal does not contain peanut products.

Patient Resources

Please read the package leaflet that comes with your medicine before using Utrogestan Vaginal.
Always use this medicine exactly as your healthcare professional has told you. If you are not sure, you can check with your doctor, pharmacist or nurse.

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

References:

1. Besins Healthcare (UK) Ltd Utrogestan Vaginal Package Leaflet. Available from https://www.medicines.org.uk/emc/files/pil.3244.pdf Last accessed: August 2023.
2. Utrogestan Vaginal Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/product/3244/smpc Last accessed: September 2022.